 | • レポートコード：GIR201113705 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、バイオ医薬品及びワクチン生産の世界市場を調査対象にし、バイオ医薬品及びワクチン生産の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（バイオ医薬品、ワクチン製造）、用途別分析（製薬、バイオテクノロジー、学術及び研究機関、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Novartis、Johnson and Johnson、Roche、Pfizer、Alexion Pharmaceuticals、Sanofi、Merck、Regeneron Pharmaceuticals、Abbott、GlaxoSmithKline、Lonza、FUJIFILM Diosynth Biotechnologies ・企業別売上、市場シェア ・バイオ医薬品及びワクチン生産の地域別市場分析 ・バイオ医薬品及びワクチン生産の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・バイオ医薬品及びワクチン生産のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・バイオ医薬品及びワクチン生産のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・バイオ医薬品及びワクチン生産の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・バイオ医薬品及びワクチン生産の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・バイオ医薬品及びワクチン生産の種類別市場規模2015-2020：バイオ医薬品、ワクチン製造 ・バイオ医薬品及びワクチン生産の用途別市場規模2015-2020：製薬、バイオテクノロジー、学術及び研究機関、その他 ・バイオ医薬品及びワクチン生産の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Biopharmaceutical and Vaccine Production market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Biopharmaceutical and Vaccine Production market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biopharmaceutical and Vaccine Production market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biopharmaceutical and Vaccine Production market has been segmented into:
Biopharmaceutical
Vaccine Production
By Application, Biopharmaceutical and Vaccine Production has been segmented into:
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biopharmaceutical and Vaccine Production market presented in the report. This section sheds light on the sales growth of different regional and country-level Biopharmaceutical and Vaccine Production markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biopharmaceutical and Vaccine Production market.
The report offers in-depth assessment of the growth and other aspects of the Biopharmaceutical and Vaccine Production market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biopharmaceutical and Vaccine Production Market Share Analysis
Biopharmaceutical and Vaccine Production competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biopharmaceutical and Vaccine Production sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biopharmaceutical and Vaccine Production sales, revenue and market share for each player covered in this report.
The major players covered in Biopharmaceutical and Vaccine Production are:
Novartis
Johnson and Johnson
Roche
Pfizer
Alexion Pharmaceuticals
Sanofi
Merck
Regeneron Pharmaceuticals
Abbott
GlaxoSmithKline
Lonza
FUJIFILM Diosynth Biotechnologies
1 Biopharmaceutical and Vaccine Production Market Overview
1.1 Product Overview and Scope of Biopharmaceutical and Vaccine Production
1.2 Classification of Biopharmaceutical and Vaccine Production by Type
1.2.1 Global Biopharmaceutical and Vaccine Production Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type in 2019
1.2.3 Biopharmaceutical
1.2.4 Vaccine Production
1.3 Global Biopharmaceutical and Vaccine Production Market by Application
1.3.1 Overview: Global Biopharmaceutical and Vaccine Production Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Global Biopharmaceutical and Vaccine Production Market by Regions
1.4.1 Global Biopharmaceutical and Vaccine Production Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biopharmaceutical and Vaccine Production (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biopharmaceutical and Vaccine Production Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical and Vaccine Production Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical and Vaccine Production Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biopharmaceutical and Vaccine Production Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical and Vaccine Production Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson and Johnson
2.2.1 Johnson and Johnson Details
2.2.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson and Johnson SWOT Analysis
2.2.4 Johnson and Johnson Product and Services
2.2.5 Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.5 Alexion Pharmaceuticals
2.5.1 Alexion Pharmaceuticals Details
2.5.2 Alexion Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Alexion Pharmaceuticals SWOT Analysis
2.5.4 Alexion Pharmaceuticals Product and Services
2.5.5 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck SWOT Analysis
2.7.4 Merck Product and Services
2.7.5 Merck Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.8 Regeneron Pharmaceuticals
2.8.1 Regeneron Pharmaceuticals Details
2.8.2 Regeneron Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Regeneron Pharmaceuticals SWOT Analysis
2.8.4 Regeneron Pharmaceuticals Product and Services
2.8.5 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abbott SWOT Analysis
2.9.4 Abbott Product and Services
2.9.5 Abbott Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline SWOT Analysis
2.10.4 GlaxoSmithKline Product and Services
2.10.5 GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.11 Lonza
2.11.1 Lonza Details
2.11.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Lonza SWOT Analysis
2.11.4 Lonza Product and Services
2.11.5 Lonza Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
2.12 FUJIFILM Diosynth Biotechnologies
2.12.1 FUJIFILM Diosynth Biotechnologies Details
2.12.2 FUJIFILM Diosynth Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 FUJIFILM Diosynth Biotechnologies SWOT Analysis
2.12.4 FUJIFILM Diosynth Biotechnologies Product and Services
2.12.5 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biopharmaceutical and Vaccine Production Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biopharmaceutical and Vaccine Production Players Market Share
3.2.2 Top 10 Biopharmaceutical and Vaccine Production Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biopharmaceutical and Vaccine Production Revenue and Market Share by Regions
4.2 North America Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
4.3 Europe Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
4.5 South America Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
5 North America Biopharmaceutical and Vaccine Production Revenue by Countries
5.1 North America Biopharmaceutical and Vaccine Production Revenue by Countries (2015-2020)
5.2 USA Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
5.3 Canada Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
5.4 Mexico Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
6 Europe Biopharmaceutical and Vaccine Production Revenue by Countries
6.1 Europe Biopharmaceutical and Vaccine Production Revenue by Countries (2015-2020)
6.2 Germany Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
6.3 UK Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
6.4 France Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
6.5 Russia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
6.6 Italy Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue by Countries
7.1 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue by Countries (2015-2020)
7.2 China Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
7.3 Japan Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
7.4 Korea Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
7.5 India Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
8 South America Biopharmaceutical and Vaccine Production Revenue by Countries
8.1 South America Biopharmaceutical and Vaccine Production Revenue by Countries (2015-2020)
8.2 Brazil Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
8.3 Argentina Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biopharmaceutical and Vaccine Production by Countries
9.1 Middle East & Africa Biopharmaceutical and Vaccine Production Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
9.3 UAE Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
9.4 Egypt Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
9.5 South Africa Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biopharmaceutical and Vaccine Production Revenue and Market Share by Type (2015-2020)
10.2 Global Biopharmaceutical and Vaccine Production Market Forecast by Type (2019-2024)
10.3 Biopharmaceutical Revenue Growth Rate (2015-2025)
10.4 Vaccine Production Revenue Growth Rate (2015-2025)
11 Global Biopharmaceutical and Vaccine Production Market Segment by Application
11.1 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2015-2020)
11.2 Biopharmaceutical and Vaccine Production Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Revenue Growth (2015-2020)
11.4 Biotechnology Revenue Growth (2015-2020)
11.5 Academic and Research Institutes Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Biopharmaceutical and Vaccine Production Market Size Forecast (2021-2025)
12.1 Global Biopharmaceutical and Vaccine Production Market Size Forecast (2021-2025)
12.2 Global Biopharmaceutical and Vaccine Production Market Forecast by Regions (2021-2025)
12.3 North America Biopharmaceutical and Vaccine Production Revenue Market Forecast (2021-2025)
12.4 Europe Biopharmaceutical and Vaccine Production Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue Market Forecast (2021-2025)
12.6 South America Biopharmaceutical and Vaccine Production Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biopharmaceutical and Vaccine Production Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biopharmaceutical and Vaccine Production Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biopharmaceutical and Vaccine Production by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biopharmaceutical and Vaccine Production Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biopharmaceutical and Vaccine Production Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Biopharmaceutical and Vaccine Production Major Business
Table 7. Novartis Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Biopharmaceutical and Vaccine Production Product and Solutions
Table 10. Novartis Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Johnson and Johnson Corporate Information, Location and Competitors
Table 12. Johnson and Johnson Biopharmaceutical and Vaccine Production Major Business
Table 13. Johnson and Johnson Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2018-2019)
Table 14. Johnson and Johnson SWOT Analysis
Table 15. Johnson and Johnson Biopharmaceutical and Vaccine Production Product and Solutions
Table 16. Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Roche Corporate Information, Location and Competitors
Table 18. Roche Biopharmaceutical and Vaccine Production Major Business
Table 19. Roche Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 20. Roche SWOT Analysis
Table 21. Roche Biopharmaceutical and Vaccine Production Product and Solutions
Table 22. Roche Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer Corporate Information, Location and Competitors
Table 24. Pfizer Biopharmaceutical and Vaccine Production Major Business
Table 25. Pfizer Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer SWOT Analysis
Table 27. Pfizer Biopharmaceutical and Vaccine Production Product and Solutions
Table 28. Pfizer Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Alexion Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Major Business
Table 31. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 32. Alexion Pharmaceuticals SWOT Analysis
Table 33. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product and Solutions
Table 34. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sanofi Corporate Information, Location and Competitors
Table 36. Sanofi Biopharmaceutical and Vaccine Production Major Business
Table 37. Sanofi Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 38. Sanofi SWOT Analysis
Table 39. Sanofi Biopharmaceutical and Vaccine Production Product and Solutions
Table 40. Sanofi Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Merck Corporate Information, Location and Competitors
Table 42. Merck Biopharmaceutical and Vaccine Production Major Business
Table 43. Merck Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 44. Merck SWOT Analysis
Table 45. Merck Biopharmaceutical and Vaccine Production Product and Solutions
Table 46. Merck Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Regeneron Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Major Business
Table 49. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 50. Regeneron Pharmaceuticals SWOT Analysis
Table 51. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product and Solutions
Table 52. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Abbott Corporate Information, Location and Competitors
Table 54. Abbott Biopharmaceutical and Vaccine Production Major Business
Table 55. Abbott Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 56. Abbott SWOT Analysis
Table 57. Abbott Biopharmaceutical and Vaccine Production Product and Solutions
Table 58. Abbott Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. GlaxoSmithKline Corporate Information, Location and Competitors
Table 60. GlaxoSmithKline Biopharmaceutical and Vaccine Production Major Business
Table 61. GlaxoSmithKline Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 62. GlaxoSmithKline SWOT Analysis
Table 63. GlaxoSmithKline Biopharmaceutical and Vaccine Production Product and Solutions
Table 64. GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Lonza Corporate Information, Location and Competitors
Table 66. Lonza Biopharmaceutical and Vaccine Production Major Business
Table 67. Lonza Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 68. Lonza SWOT Analysis
Table 69. Lonza Biopharmaceutical and Vaccine Production Product and Solutions
Table 70. Lonza Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. FUJIFILM Diosynth Biotechnologies Corporate Information, Location and Competitors
Table 72. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Major Business
Table 73. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Total Revenue (USD Million) (2017-2018)
Table 74. FUJIFILM Diosynth Biotechnologies SWOT Analysis
Table 75. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product and Solutions
Table 76. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Biopharmaceutical and Vaccine Production Revenue (Million USD) by Players (2015-2020)
Table 78. Global Biopharmaceutical and Vaccine Production Revenue Share by Players (2015-2020)
Table 79. Global Biopharmaceutical and Vaccine Production Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Regions (2015-2020)
Table 81. North America Biopharmaceutical and Vaccine Production Revenue by Countries (2015-2020)
Table 82. North America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2015-2020)
Table 83. Europe Biopharmaceutical and Vaccine Production Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Biopharmaceutical and Vaccine Production Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Biopharmaceutical and Vaccine Production Revenue by Countries (2015-2020)
Table 86. South America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Biopharmaceutical and Vaccine Production Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2015-2020)
Table 89. Global Biopharmaceutical and Vaccine Production Revenue (Million USD) by Type (2015-2020)
Table 90. Global Biopharmaceutical and Vaccine Production Revenue Share by Type (2015-2020)
Table 91. Global Biopharmaceutical and Vaccine Production Revenue Forecast by Type (2021-2025)
Table 92. Global Biopharmaceutical and Vaccine Production Revenue by Application (2015-2020)
Table 93. Global Biopharmaceutical and Vaccine Production Revenue Share by Application (2015-2020)
Table 94. Global Biopharmaceutical and Vaccine Production Revenue Forecast by Application (2021-2025)
Table 95. Global Biopharmaceutical and Vaccine Production Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biopharmaceutical and Vaccine Production Picture
Figure 2. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type in 2019
Figure 3. Biopharmaceutical Picture
Figure 4. Vaccine Production Picture
Figure 5. Biopharmaceutical and Vaccine Production Revenue Market Share by Application in 2019
Figure 6. Pharmaceutical Picture
Figure 7. Biotechnology Picture
Figure 8. Academic and Research Institutes Picture
Figure 9. Others Picture
Figure 10. Global Biopharmaceutical and Vaccine Production Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Biopharmaceutical and Vaccine Production Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Biopharmaceutical and Vaccine Production Revenue Market Share in 2019
Figure 19. Global Top 10 Players Biopharmaceutical and Vaccine Production Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Regions (2015-2020)
Figure 23. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Regions in 2018
Figure 24. North America Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 25. Europe Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 27. South America Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 29. North America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2015-2020)
Figure 30. North America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries in 2019
Figure 31. USA Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 32. Canada Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 34. Europe Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Biopharmaceutical and Vaccine Production Revenue Market Share by Countries in 2019
Figure 36. Germany Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 37. UK Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 38. France Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 39. Russia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 40. Italy Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Biopharmaceutical and Vaccine Production Revenue Market Share by Countries in 2019
Figure 43. China Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 44. Japan Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 45. Korea Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 46. India Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 48. South America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2015-2020)
Figure 49. South America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries in 2019
Figure 50. Brazil Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Biopharmaceutical and Vaccine Production Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 55. UAE Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2015-2020)
Figure 58. Global Biopharmaceutical and Vaccine Production Revenue Share by Type (2015-2020)
Figure 59. Global Biopharmaceutical and Vaccine Production Revenue Share by Type in 2019
Figure 60. Global Biopharmaceutical and Vaccine Production Market Share Forecast by Type (2021-2025)
Figure 61. Global Biopharmaceutical Revenue Growth Rate (2015-2020)
Figure 62. Global Vaccine Production Revenue Growth Rate (2015-2020)
Figure 63. Global Biopharmaceutical and Vaccine Production Revenue Share by Application (2015-2020)
Figure 64. Global Biopharmaceutical and Vaccine Production Revenue Share by Application in 2019
Figure 65. Global Biopharmaceutical and Vaccine Production Market Share Forecast by Application (2021-2025)
Figure 66. Global Pharmaceutical Revenue Growth Rate (2015-2020)
Figure 67. Global Biotechnology Revenue Growth Rate (2015-2020)
Figure 68. Global Academic and Research Institutes Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Biopharmaceutical and Vaccine Production Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Biopharmaceutical and Vaccine Production Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Biopharmaceutical and Vaccine Production Revenue Market Forecast (2021-2025)
Figure 74. Europe Biopharmaceutical and Vaccine Production Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Biopharmaceutical and Vaccine Production Revenue Market Forecast (2021-2025)
Figure 76. South America Biopharmaceutical and Vaccine Production Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Biopharmaceutical and Vaccine Production Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
バイオ医薬品及びワクチンの世界市場 2020年 Market Overview The global Biopharmaceutical and Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biopharmaceuti…- 鼻インフルエンザワクチンの世界市場 2020年 Market Overview The Nasal Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 点鼻薬ワクチンの世界市場 2020年 Market Overview The Nasal Spray Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 肺炎球菌ワクチンの世界市場 2020年 Market Overview The Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 髄膜炎菌感染症ワクチンの世界市場 2020年 Market Overview The global Meningococcal Infections Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meningococca…